Comparison of cardiovascular mortality between MAFLD and NAFLD: A cohort study

被引:9
|
作者
Yoo, Tae Kyung [1 ]
Lee, Mi Yeon [2 ]
Kim, Seong Hwan [3 ]
Zheng, Ming-Hua [4 ,5 ,6 ,7 ]
Targher, Giovanni [8 ]
Byrne, Christopher D. [9 ,10 ]
Sung, Ki-Chul [11 ,12 ]
机构
[1] MetroWest Med Ctr, Dept Med, Framingham, MA USA
[2] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept R&D Management, Div Biostat,Sch Med, Seoul, South Korea
[3] Korea Univ, Ansan Hosp, Div Cardiol, Dept Internal Med, Ansan, South Korea
[4] Wenzhou Med Univ, MAFLD Res Ctr, Affiliated Hosp 1, Dept Hepatol, Wenzhou, Peoples R China
[5] Wenzhou Key Lab Hepatol, Wenzhou, Peoples R China
[6] Wenzhou Med Univ, Inst Hepatol, Wenzhou, Peoples R China
[7] Key Lab Diag & Treatment Dev Chron Liver Dis Zheji, Wenzhou, Peoples R China
[8] Univ & Azienda Osped Univ Integrata Verona, Dept Med, Sect Endocrinol Diabet & Metab, Verona, Italy
[9] Univ Southampton, Fac Med, Nutr & Metab, Southampton, England
[10] Univ Hosp Southampton, Southampton Natl Inst Hlth Res, Biomed Res Ctr, Southampton, England
[11] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Internal Med, Div Cardiol,Sch Med, Seoul, South Korea
[12] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Internal Med, Div Cardiol,Sch Med, 108, Pyung Dong, Seoul 110746, South Korea
关键词
MAFLD; NAFLD; Cardiovascular disease mortality; FATTY LIVER-DISEASE; ASSOCIATION; RESOLUTION; OBESITY; RISK;
D O I
10.1016/j.numecd.2023.01.013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and aims: A new diagnostic criterion of metabolic dysfunction-associated fatty liver disease (MAFLD) has been proposed. However, only few studies have shown that MAFLD predicts cardiovascular disease (CVD) mortality better than non-alcoholic fatty liver disease (NAFLD). Therefore, a cohort study was conducted to assess this relationship. Methods and results: Health examination data from health care centers in South Korea were assessed after excluding participants with missing covariates and cancer history (n Z 701,664). Liver ultrasonography reports, laboratory and anthropometric data were extracted. Diagnoses of NAFLD and MAFLD were performed according to standard definitions. Participants were categorized based on the presence of NAFLD and MAFLD. In addition, participants were classified into five categories: no fatty liver disease (no FLD), NAFLD-only, MAFLD-only, both FLDs, and alcoholic FLD (AFLD) and non-MAFLD. Multivariable regression modeling was performed. The median follow-up duration was 8.77 years, and 52.56% of participants were men. After stratifying the cohort into no-MAFLD and MAFLD groups, MAFLD was associated with increased CVD mortality (adjusted HR 1.14, 95% CI 1.02-1.28). When participants were divided into noNAFLD and NAFLD groups, there was a non-significant trend towards an increase in CVD mortality in NAFLD group (adjusted HR 1.07, 95% CI 0.95-1.21). When participants were divided into five categories, MAFLD-only group showed increased CVD mortality (adjusted HR 1.35, 95% CI 1.07-1.70 ) while NAFLD-only group showed no significant association with CVD mortality (adjusted HR 0.67, 95% CI 0.38-1.19). Conclusions: In conclusion, MAFLD is associated with increased CVD mortality in a relatively young Korean population. (c) 2023 The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:947 / 955
页数:9
相关论文
共 50 条
  • [1] Comparison of MAFLD and NAFLD Characteristics in Children
    Xing, Yunfei
    Fan, Jiangao
    Wang, Hai-Jun
    Wang, Hui
    [J]. CHILDREN-BASEL, 2023, 10 (03):
  • [2] Comparison of NAFLD, MAFLD and MASLD characteristics and mortality outcomes in United States adults
    Song, Rui
    Li, Zhao
    Zhang, Yingzhi
    Tan, Jiahe
    Chen, Zhiwei
    [J]. LIVER INTERNATIONAL, 2024, 44 (04) : 1051 - 1060
  • [3] The Transition of Cardiovascular Disease Risks from NAFLD to MAFLD
    Yang, Zifeng
    Yang, Juan
    Cai, Jingjing
    Zhang, Xiao-Jing
    Zhang, Peng
    She, Zhi-Gang
    Li, Hongliang
    [J]. REVIEWS IN CARDIOVASCULAR MEDICINE, 2023, 24 (06)
  • [4] Discrepancy Between NAFLD and MAFLD: Is it Only Due to Misclassification of MAFLD? Reply
    Tang, Ansel Shao Pin
    Ng, Cheng Han
    Muthiah, Mark D.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (03) : 849 - 850
  • [5] Does the risk of cardiovascular events differ between biopsy-proven NAFLD and MAFLD?
    Gabriel Tayguara Silveira Guerreiro
    Larisse Longo
    Mariana Alves Fonseca
    Valessa Emanoele Gabriel de Souza
    Mário Reis Álvares-da-Silva
    [J]. Hepatology International, 2021, 15 : 380 - 391
  • [6] Does the risk of cardiovascular events differ between biopsy-proven NAFLD and MAFLD?
    Silveira Guerreiro, Gabriel Tayguara
    Longo, Larisse
    Fonseca, Mariana Alves
    Gabriel de Souza, Valessa Emanoele
    Alvares-da-Silva, Mario Reis
    [J]. HEPATOLOGY INTERNATIONAL, 2021, 15 (02) : 380 - 391
  • [7] From NAFLD to MAFLD: Definition, Pathophysiological Basis and Cardiovascular Implications
    Boccatonda, Andrea
    Andreetto, Lorenzo
    D'Ardes, Damiano
    Cocco, Giulio
    Rossi, Ilaria
    Vicari, Susanna
    Schiavone, Cosima
    Cipollone, Francesco
    Guagnano, Maria Teresa
    [J]. BIOMEDICINES, 2023, 11 (03)
  • [8] Outcomes of NAFLD and MAFLD: Results from a community-based, prospective cohort study
    Niriella, Madunil Anuk
    Ediriweera, Dileepa Senajith
    Kasturiratne, Anuradhani
    De Silva, Shamila Thivanshi
    Dassanayaka, Anuradha Supun
    De Silva, Arjuna Priyadarshin
    Kato, Norihiro
    Pathmeswaran, Arunasalam
    Wickramasinghe, Ananda Rajitha
    de Silva, Hithanadura Janaka
    [J]. PLOS ONE, 2021, 16 (02):
  • [9] Differential Clinical Characteristics and Mortality Outcomes in Persons With NAFLD and/or MAFLD
    Nguyen, Vy H.
    Le, Michael H.
    Cheung, Ramsey C.
    Nguyen, Mindie H.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2021, 19 (10) : 2172 - +
  • [10] Cardiovascular and renal burdens among patients with MAFLD and NAFLD in China
    Wang, Yuying
    Yu, Yuetian
    Zhang, Haojie
    Chen, Chi
    Wan, Heng
    Chen, Yi
    Xia, Fangzhen
    Yu, Shiyan
    Wang, Ningjian
    Ye, Lin
    Lu, Yingli
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2022, 13